This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
November 2022Metro Washington DC Area

Daniel Lagassé
Biologist, DPPT, OTAT, CBER at FDA CBER

Profile

Dr. Lagassé conducts research and performs regulatory CMC Product Quality review as a Biologist at the U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics.  Dr. Lagassé received his PhD in Molecular Microbiology and Immunology from Johns Hopkins Bloomberg School of Public Health.

Agenda Sessions

  • FDA Address: Characterization of Novel Therapeutic Protein Products with Respect to Immunogenicity

    3:35pm
  • Regulatory Town Hall

    12:40pm